{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:17:43Z","timestamp":1787685463808,"version":"build-2784847793"},"reference-count":26,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"3","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>La histiocitosis de c\u00e9lulas de Langerhans comprende un grupo heterog\u00e9neo de enfermedades inflamatorias cuyos principales componentes celulares son las c\u00e9lulas dendr\u00edticas y los macr\u00f3fagos. El infiltrado inflamatorio puede afectar la piel y otros \u00f3rganos, y el resultado cl\u00ednico var\u00eda de leve a letal, dependiendo del subconjunto de c\u00e9lulas involucradas y el compromiso multisist\u00e9mico. La demora en el diagn\u00f3stico puede ocurrir debido a su presentaci\u00f3n inespec\u00edfica y a que los m\u00e9dicos tratantes no suelen sospecharla.Se reporta el caso de una lactante mayor a la cual, a pesar de m\u00faltiples consultas con s\u00edntomas inespec\u00edficos pero caracter\u00edsticos de la enfermedad, solamente se le pudo hacer el diagn\u00f3stico gracias a los hallazgos histopatol\u00f3gicos.<\/jats:p>","DOI":"10.7705\/biomedica.5430","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T16:26:36Z","timestamp":1632500796000},"page":"396-402","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":3,"title":["Histiocitosis de c\u00e9lulas de Langerhans: reporte de caso y revisi\u00f3n de la literatura"],"prefix":"10.7705","volume":"41","author":[{"given":"Miguel \u00c1ngel","family":"Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Echeverri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Builes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"105052","doi-asserted-by":"crossref","unstructured":"Venkatramani R, Rosenberg S, Indramohan G, Jeng M, Jubran R. An exploratory epidemiological study of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2012;59:1324-6. https:\/\/doi.org\/10.1002\/pbc.24136","DOI":"10.1002\/pbc.24136"},{"key":"105053","doi-asserted-by":"crossref","unstructured":"Guyot-Goubin A, Donadieu J, Barkaoui M, Bellec S, Thomas C, Clavel J. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer. 2008;51:71-5. https:\/\/doi.org\/10.1002\/pbc.21498","DOI":"10.1002\/pbc.21498"},{"key":"105054","unstructured":"Mor\u00e1n E, Dur\u00e1n C, Orozco L, Palacios C, S\u00e1ez-de-Oc\u00e1riz M, Garc\u00eda M. Histiocitosis de c\u00e9lulas de Langerhans: nuevos conceptos. Dermatolog\u00eda Cosm\u00e9tica, M\u00e9dica y Quir\u00fargica. 2018;16:36-44."},{"key":"105055","doi-asserted-by":"crossref","unstructured":"Leung AK, Lam JM, Leong KF. Childhood Langerhans cell histiocytosis: A disease with many faces. World J Pediatr. 2019;15:536-45. https:\/\/doi.org\/10.1007\/s12519-019-00304-9","DOI":"10.1007\/s12519-019-00304-9"},{"key":"105056","doi-asserted-by":"crossref","unstructured":"Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2015;212:281. https:\/\/doi.org\/ 10.1084\/jem.2013097701202015c","DOI":"10.1084\/jem.2013097701202015c"},{"key":"105057","doi-asserted-by":"crossref","unstructured":"Minkov M. Multisystem Langerhans cell histiocytosis in children: Current treatment and future directions. Paediatr Drugs. 2011;13:75-86. https:\/\/doi.org\/10.2165\/11538540-000000000-00000","DOI":"10.2165\/11538540-000000000-00000"},{"key":"105058","unstructured":"G\u00f3mez AM, Lotero V, Mart\u00ednez P, Medina D, Ram\u00edrez O. Histiocitosis de c\u00e9lulas de Langerhans en ni\u00f1os. Descripcion de 10 casos. Revista CES Med. 2013;27:177-84."},{"key":"105059","doi-asserted-by":"crossref","unstructured":"Poompuen S, Chaiyarit J, Techasatian L. Diverse cutaneous manifestation of Langerhans cell histiocytosis: A 10-year retrospective cohort study. Eur J Pediatr. 2019;178:771-6. https:\/\/doi.org\/:10.1007\/s00431-019-03356-1","DOI":"10.1007\/s00431-019-03356-1"},{"key":"105060","doi-asserted-by":"crossref","unstructured":"Nann D, Schneckenburger P, Steinhilber J, Metzler G, Beschorner R, Schwarze CP, et al. Pediatric Langerhans cell histiocytosis: The impact of mutational profile on clinical progression and late sequelae. Ann Hematol. 2019;98:1617-26. https:\/\/doi.org\/10.1007\/s00277-019-03678-y","DOI":"10.1007\/s00277-019-03678-y"},{"key":"105061","unstructured":"Thacker NH, Abla O. Pediatric Langerhans cell histiocytosis: State of the science and future directions. Clin Adv Hematol Oncol. 2019;17:122-31."},{"key":"105062","doi-asserted-by":"crossref","unstructured":"St\u00e5lemark H, Laurencikas E, Karis J, Gavhed D, Fadeel B, Henter JI. Incidence of Langerhans cell histiocytosis in children: A population-based study. Pediatr Blood Cancer. 2008;51:76-81. https:\/\/doi.org\/10.1002\/pbc.21504","DOI":"10.1002\/pbc.21504"},{"key":"105063","doi-asserted-by":"crossref","unstructured":"Laman JD, Leenen PJ, Annels NE, Hogendoorn PC, Egeler RM. Langerhans-cell histiocytosis \u2018insight into DC biology\u2019. Trends Immunol. 2003;24:190-6. https:\/\/doi.org\/10.1016\/s1471-4906(03)00063-2","DOI":"10.1016\/S1471-4906(03)00063-2"},{"key":"105064","doi-asserted-by":"crossref","unstructured":"Haroche J, Cohen-Aubart F, Rollins BJ, Donadieu J, Charlotte F, Idbaih A, et al. Histiocytoses: Emerging neoplasia behind inflammation. Lancet Oncol. 2017;18:e113-25. https:\/\/doi.org\/10.1016\/S1470-2045(17)30031-1","DOI":"10.1016\/S1470-2045(17)30031-1"},{"key":"105065","doi-asserted-by":"crossref","unstructured":"Nelson DS, Quispel W, Badalian-Very G, van Halteren AG, van den Bos C, Bov\u00e9e JV, et al. Somatic activating ARAF mutations in Langerhans cell histiocytosis. Blood. 2014;123:3152-5. https:\/\/doi.org\/10.1182\/blood-2013-06-511139","DOI":"10.1182\/blood-2013-06-511139"},{"key":"105066","doi-asserted-by":"crossref","unstructured":"Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672-81. https:\/\/doi.org\/10.1182\/blood-2016-01-690636","DOI":"10.1182\/blood-2016-01-690636"},{"key":"105067","doi-asserted-by":"crossref","unstructured":"Grois N, Fahrner B, Arceci RJ, Henter JI, McClain K, Lassmann H, et al. Central nervous system disease in Langerhans cell histiocytosis. J Pediatr. 2010;156:873-81. https:\/\/doi.org\/10.1016\/j.jpeds.2010.03.001","DOI":"10.1016\/j.jpeds.2010.03.001"},{"key":"105068","doi-asserted-by":"crossref","unstructured":"Atsumi Y, Saito Y, Hataya H, Yuza Y. Initial symptoms of Langerhans cell histiocytosis: A case series. Glob Pediatr Health. 2019;19:2333794X19857377. https:\/\/doi.org\/10.1177\/2333794X19857377","DOI":"10.1177\/2333794X19857377"},{"key":"105069","doi-asserted-by":"crossref","unstructured":"Kim JE, Yi WJ, Heo MS, Lee SS, Choi SC, Huh KH. Langerhans cell histiocytosis of the jaw, a mimicker of osteomyelitis on CT and MR images: A retrospective analysis. Medicine (Baltimore). 2019;98:e16331. https:\/\/doi.org\/:10.1097\/MD.0000000000016331","DOI":"10.1097\/MD.0000000000016331"},{"key":"105070","doi-asserted-by":"crossref","unstructured":"Aric\u00f2 M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12:247-58. https:\/\/doi.org\/10.1016\/s0889-8588(05)70508-6","DOI":"10.1016\/S0889-8588(05)70508-6"},{"key":"105071","unstructured":"Broadbent V, Egeler RM, Nesbit ME Jr. Langerhans cell histiocytosis--clinical and epidemiological aspects. Br J Cancer Suppl. 1994;23:S11-6."},{"key":"105072","doi-asserted-by":"crossref","unstructured":"Donadieu J, Rolon MA, Thomas C, Brugieres L, Plantaz D, Emile JF, et al. Endocrine involvement in pediatric-onset Langerhans\u2019 cell histiocytosis: A population-based study. J Pediatr. 2004;144:344-50. https:\/\/doi.org\/10.1016\/j.jpeds.2003.12.030","DOI":"10.1016\/j.jpeds.2003.12.030"},{"key":"105073","doi-asserted-by":"crossref","unstructured":"Le Guennec L, Decaix C, Donadieu J, Santiago-Ribeiro M, Martin-Duverneuil N, Levy R, et al. The cognitive spectrum in neurodegenerative Langerhans cell histiocytosis. J Neurol. 2014;261:1537-43. https:\/\/doi.org\/10.1007\/s00415-014-7375-y","DOI":"10.1007\/s00415-014-7375-y"},{"key":"105074","doi-asserted-by":"crossref","unstructured":"Grois N, P\u00f6tschger U, Prosch H, Minkov M, Arico M, Braier J, et al. Risk factors for diabetes insipidus in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2006;46:228-33. https:\/\/doi.org\/:10.1002\/pbc.20425","DOI":"10.1002\/pbc.20425"},{"key":"105075","doi-asserted-by":"crossref","unstructured":"Allen CE, Ladisch S, McClain KL. How I treat Langerhans cell histiocytosis. Blood. 2015;126:26-35. https:\/\/doi.org\/10.1182\/blood-2014-12-569301","DOI":"10.1182\/blood-2014-12-569301"},{"key":"105076","unstructured":"Khanbabaee G, HassasYeganeh M, Tabatabaei SA, Khatami A, Bazrafshan S, Rezaei N. Langerhans cell histiocytosis with pulmonary involvement and unilateral pneumothorax. Turk J Pediatr. 2010;52:638-41."},{"key":"105077","doi-asserted-by":"crossref","unstructured":"Jessop S, Crudgington D, London K, Kellie S, Howman-Giles R. FDG PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Blood Cancer. 2020;67:e28034. https:\/\/doi.org\/10.1002\/pbc.28034","DOI":"10.1002\/pbc.28034"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5430\/4803","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5430\/4803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T19:12:04Z","timestamp":1632510724000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/5430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,22]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.5430","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"assertion":[{"value":"2021-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Case presentation","name":"content_type","label":"Content Type"}]}}